TeselaGen

Founded: 2011
Company Size: 1-10 employees
Location: United States
Market(s): Genome Editing, CAD Tools
Last Funding Closed: Grant
Funding to Date: $750,000
Company Overview

TeselaGen is accelerating synthetic biology with their fully automated “Mind to Molecule” software suite for designing and building complex DNA molecules and combinatorial DNA libraries. The system constitutes a rapid prototyping system for synthetic biology enabling companies to build better biologic drugs to cure disease, and more sustainable bio-based chemicals.

TeselaGen’s first offering is a computer-aided design and manufacturing (CAD/CAM) tool to help companies design complex protocols for the assembly of DNA libraries. Plans, supported by the National Science Foundation, include integration of the assembler output with automation for building DNA libraries of arbitrary length and complexity without human intervention.

TeselaGen’s recognition includes a Bio-IT World Best Practices Award in 2013, and grant awards from the National Science Foundation and the Department of Energy.

Funding Details

National Science Foundation SBIR Phase II Award

Key People
Mike Fero, Founder and Chief Executive Officer
Eduardo Abeliuk, Founder and Chief Technology Officer
Nathan Hillson, Founder and Chief Scientific Officer

Comments are closed.